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ABSTRACT 
Diabetes mellitus is metabolic disorder it is caused by an absolute or relative lack of insulin that, among other consequences, to increase in 
plasma glucose concentration associated with change hyperglycemia and disturbance of lipid metabolism, carbohydrate metabolis m, also 
protein metabolism. Absolute lack of insulin called as Type 1 diabetes mellitus also called as juvenile diabetes. The condition caused by a lesion 
in the beta cells of the pancreas. Type 2 diabetes is a long term metabolic disorder that characterized by  high blood sugar , insulin resistance 
,and relative lack of insulin/ The prepared tablets were adequately hard to withstand pressure the hardness ranged from (2.91-3.67). The 
friability from the tablets was less which represent less loss of free particles. The weight variation and wetting were within limits. The 
dissolution of prepared tablets was relatively fast.  
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INTRODUCTION 
Diabetes mellitus is known as blood-sugar disease. The 
pancreas fails to perform its appropriate function to 
stimulate insulin production in diabetic patients. The 
prevalence of type 2 diabetes mellitus (T2DM) has increased 
dramatically during recent decades and now it is a serious 
global health burden. According to the International Diabetes 
Federation 2015 report, the ratio of diabetic patients in the 
world is one out of eleven adults. Diabetes mellitus and its 
related complications are major causes of death in various 
countries. Diabetes mellitus (DM) is a metabolic disorder 
characterised by hyperglycaemia and interruption of the 
metabolism of protein, carbohydrate and fat. It may be 
associated with distinctive symptoms, such as polyuria 
(frequent urination), polydipsia (increased thirst) and 
polyphagia (increased hunger)[1]. DM is an important public 
health concern that affects more than 170 million individuals 
worldwide. It is expected that the number of people suffering 
from diabetes in the UK will reach approximately 5 million, 
or almost 10% of the population, by 2025 and it is one of the 
leading causes of death worldwide. Diabetes is a multi-organ 
disease independent of age, race and gender. A number of 
pathogenic actions are involved in the progress of diabetes, 
including destruction of the beta cells of the pancreas, which 
leads to insulin deficiency. Some of the processes can cause 
resistance to insulin, leading to increased plasma glucose 
levels and abnormalities of carbohydrate, fat and protein 
metabolism[2]. Diabetes is classified into four groups: type 1, 
type 2, gestational and maturity onset diabetes of the young 
(MODY). Type 2 diabetes is a group of progressive disorders 
characterised by high blood glucose levels caused by a lack of 
insulin activity which can arise from a combination of 
impaired insulin secretion and impaired response to insulin 
in key tissues and organs, known as insulin resistance[3]. One 
consequence is that gluconeogenesis in the liver is no longer 
inhibited by insulin, and thus increases. Insulin resistance 
means that the body is unable to use insulin efficiently, 
because target tissues become unresponsive to insulin. Type- 
2 diabetes develops most often in middle-aged and older 
adults, but increasingly is appearing in children, teenagers 
and young adults[4]. It accounts for about 90% of cases of 
diabetes. Patients with this type of diabetes may not require 
insulin to survive. Type 2 diabetes is often a result of excess 
body weight and physical inactivity in genetically 
predisposed individuals and is the most common type[5]. 
Glipizide, a second-generation sulfonylurea, is used with diet 
to lower blood glucose in patients with diabetes mellitus 
type II. The primary mode of action of glipizide in 
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experimental animals appears to be the stimulation of 
insulin secretion from the beta cells of pancreatic islet tissue 
and is thus dependent on functioning beta cells in the 
pancreatic islets. In humans glipizide appears to lower the 
blood glucose acutely by stimulating the release of insulin 
from the pancreas, an effect dependent upon functioning 
beta cells in the pancreatic islets. In man, stimulation of 
insulin secretion by glipizide in response to a meal is 
undoubtedly of major importance. Fasting insulin levels are 
not elevated even on long-term glipizide administration, but 
the postprandial insulin response continues to be enhanced 
after at least 6 months of treatment.  
Some patients fail to respond initially, or gradually lose their 
responsiveness to sulfonylurea drugs, including glipizide. For 
use as an adjunct to diet for the control of hyperglycemia[6–8] 
and its associated symptomatology in patients with non-
insulin-dependent diabetes mellitus (NIDDM; type II), 
formerly known as maturity-onset diabetes, after an 
adequate trial of dietary therapy has proved unsatisfactory. 
The present work was aimed to formulate and evaluate fast 
dissolving tablets of glipizide. 
MATERIALS AND METHODS 
Drug and Chemicals  
Glipizide was received as a gift sample from Ipca 
Laboratories Ltd, Ratlam and other excipients such as talc, 
sodium starch glycolate, lactose were obtained from the CDH, 
Mumbai. 
Method of Preparation 
Glipizide was mixed with sodium starch glycolate and 
lactose, talc was added. The blend was mixed properly and 
sieved (Table 1). The blend was compressed to prepare 
tablets
 
Table 1: Composition of Glipizide fast dissolving tablet Ingredients 
Excipients F1 F2 F3 F4 F5 
Glipizide 5 5 5 5 5 
Croscarmelose 2 5 2 5 0 
Sodium starch glycolate 3 3 6 6 0 
Lactose 60 60 60 60 60 
MCC 30 30 30 30 30 
Magnesium stearate 5 5 5 5 5 
Talc 3 3 3 3 3 
 
Evaluation of Formulated Tablets 
Micromeretics 
 Angle of Repose  
Angle of repose was determined using fixed funnel method. 
The blend was poured through a funnel that can be raised 
vertically until a maximum cone height (h) was obtained. 
Radius of the heap (r) was measured and the angle of repose 
(ө) was calculated using the formula[9]. 
θ = tan -1 (h / r) 
 Bulk Density  
Bulk density was determined by pouring the blend into a 
graduated cylinder. The bulk volume (V) and weight of the 
powder (M) was determined. The bulk density [9] was 
calculated by using the below mentioned formula, 
             
                
      
 
 Tapped Density  
The measuring cylinder containing a known mass of blend 
was tapped for a fixed time. The minimum volume (Vt) 
occupied in the cylinder and the weight (M) of the blend was 
measured. The tapped density [9] was calculated using the 
following formula 
               
               
                           
 
 Compressibility Index  
The simplest way for measurement of free flow of powder is 
compressibility , a indication of the ease with which a 
material can be induced to flow is given by compressibility 
index (I) [10]which is calculated as follows, 
  
     
   
 
Here, VO is bulk volume and Vt is tapped volume. The value 
below 15% indicates a powder with usually give rise to good 
flow characteristics, whereas above 25% indicate poor flow 
ability. 
 Hausner’s Ratio  
Hausner’s ratio is an indirect index of ease of powder 
flow[10]. It is calculated by the following formula, 
              
              
            
 
Lower Hausner’s ratio (<1.25) indicates better flow 
properties than higher ones (>1.25). 
Thickness 
Thickness of tablet was determined by using vernier calliper 
(Mitutoya, Model CD-6 CS, Japan). 
Hardness  
The crushing strength of the tablets was measured using a 
Monsanto hardness tester (Sheetal Scientific Industries, 
Mumbai, India). Three tablets from each formulation batch 
were tested randomly [11] and the average reading noted. 
Friability  
Twenty tablets were weighed and placed in a Roche 
friabilator (Electrolab, India). Twenty reweighed tablets 
were rotated at 25 rpm for 4 min. The tablets were then 
dedusted and reweighed and the percentage of weight loss 
was calculated. The percentage friability of the tablets were 
measured [11] as per the following formula,  
                      
                         
             
      
Weight Variation  
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Randomly, twenty tablets were selected after compression 
and the mean weight was determined[11]. None of the tablets 
deviated from the average weight by more than ±7.5%. 
Wetting Time  
A piece of circular tissue paper (8cm) folded twice was 
placed in a Petri dish (Internal Diameter = 9 cm) containing 
10 ml of buffer solution simulating saliva pH 6.8. A tablet 
was placed on the paper and the time taken for complete 
wetting was noted. Three tablets from each formulation 
were randomly selected and the average wetting time was 
noted [12]. The results are tabulated in Table 2. 
In Vitro Dispersion Time  
In vitro dispersion time of prepared tablet was done by 
dropping the tablet in 10 ml measuring cylinder containing 6 
ml of simulated salivary fluid (pH 6.8). Time required for 
complete dispersion of tablet was measured [13]. 
Dissolution Study 
In vitro release of Glipizide from tablets was monitored by 
using 900 ml of simulated intestinal fluid, SIF (USP 
phosphate buffer solution, pH 7.4) at 37±0.5°C and 50 rpm 
using programmable dissolution tester [Paddle type, model 
TDT-08L, Electrolab, (USP), India]. 5 ml Aliquots were 
withdrawn at one minute time intervals and were 
replenished immediately with the same volume of fresh 
buffer medium. Aliquots, following suitable dilutions, were 
assayed spectrophotometrically (UV-1700, Shimadzu,Japan) 
at 378 nm. 
RESULTS & DISCUSSION 
Five formulations of glipizide were prepared with different 
concentration of the four individual Superdisintegrants: 
Croscarmelose and Sodium starch glycolate. For each 
formulation, blend of drug and excipients were prepared 
and evaluated for various parameters as explained earlier. 
The powder blend was compressed using direct 
compression technique. Bulk density was found in the range 
of 0.45 – 0.43 g/cm3 and the tapped density between 0.35 – 
0.38 g/cm3. By using these two density data, Hausner’s ratio 
and compressibility index was calculated. The 
compressibility index was found between 13.27 and 20.32 
and the compressibility correlation data indicated a fairly 
good flowability of the powder blend. The good flowability 
of the powder blend was also evidenced with angle of repose 
(range of 20.12 –25.97), which is below 40º indicating good 
flowability. Micromeretic results of the all batches were 
shown in Table 2.  
 
Table 2: Characterization of Glipizide Tablets 
Parameters F1 F2 F3 F4 F5 
Hardness (kg/cm2) 3.01±0.24 3.24±0.56 2.91±0.22 3.11±0.54 3.67±0.12 
Friability (%) 0.744± 0.024 0.647±0.062 0.645±0.053 0.621±0.042 0.589±0.054 
Weight variation (mg) 100±3 99±2 101±3 101±1 105±1 
Thickness (mm) 3.51±0.013 3.44±0.075 3.67±0.045 3.45±0.046 3.53±0.041 
Wetting time (s) 16.25±2.5 15.3±1.5 13.6±2.2 14.1±2.0 14.4±1.5 
In-vitro dispersion time (s) 30.32±2.51 28.14±1.14 26.24±2.24 25.74±3.27 24.84±2.25 
Results are expressed as mean±SD (n=3) 
The prepared tablets were adequately hard to withstand pressure the hardness ranged from (2.91-3.67). The friability from the 
tablets was less which represent less loss of free particles. The weight variation and wetting were within limits.  
Table 3: Micromeretics of Glipizide Blend 
Formulation 
Code 
Bulk density 
(gm/ml) 
Tapped density 
(gm/ml) 
Angle of repose 
(θ) 
Percentage 
compressibility 
Hausner’s 
Ratio 
F 1 0.45 0.38 25.97 20.32 1.15 
F 2 0.45 0.38 24.84 18.24 1.21 
F 3 0.44 0.37 25.34 16.52 1.23 
F 4 0.43 0.36 22.55 14.23 1.24 
F 5 0.43 0.35 20.12 13.27 1.26 
Results are expressed as mean±SD (n=3) 
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Figure 1: Dissolution studies of prepared tablets (n=3) 
Results are expressed as mean±SD 
The dissolution of prepared tablets was relatively fast. These 
results indicated that dissolution parameter values of 
croscarmellose sodium and sodium starch glycolate [14] 
containing tablets are in consistent with the disintegration 
time values observed.  
CONCLUSION 
In the light of the results, our study indicates that Glipizide 
tablets may have good antidiabetic activity. The immediate 
release effect of drug may be responsible for rapid reduction 
of blood glucose levels.   
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